» Articles » PMID: 18083844

Chemokines and the Pathophysiology of Neuropathic Pain

Overview
Specialty Science
Date 2007 Dec 18
PMID 18083844
Citations 157
Authors
Affiliations
Soon will be listed here.
Abstract

Chemokines and chemokine receptors are widely expressed by cells of the immune and nervous systems. This review focuses on our current knowledge concerning the role of chemokines in the pathophysiology of chronic pain syndromes. Injury- or disease-induced changes in the expression of diverse chemokines and their receptors have been demonstrated in the neural and nonneural elements of pain pathways. Under these circumstances, chemokines have been shown to modulate the electrical activity of neurons by multiple regulatory pathways including increases in neurotransmitter release through Ca-dependent mechanisms and transactivation of transient receptor channels. Either of these mechanisms alone, or in combination, may contribute to sustained excitability of primary afferent and secondary neurons within spinal pain pathways. Another manner in which chemokines may influence sustained neuronal excitability may be their ability to function as excitatory neurotransmitters within the peripheral and central nervous system. As is the case for traditional neurotransmitters, injury-induced up-regulated chemokines are found within synaptic vesicles. Chemokines released after depolarization of the cell membrane can then act on other chemokine receptor-bearing neurons, glia, or immune cells. Because up-regulation of chemokines and their receptors may be one of the mechanisms that directly or indirectly contribute to the development and maintenance of chronic pain, these molecules may then represent novel targets for therapeutic intervention in chronic pain states.

Citing Articles

Advanced cancer perineural invasion induces profound peripheral neuronal plasticity, pain, and somatosensory mechanical deactivation, unmitigated by the lack of TNFR1. Part. 1: Behavior and single-cell in vivo electrophysiology.

Gutierrez S, Parker R, Parker R, Zhang M, Santi M, Ye Y Mol Pain. 2025; 21:17448069251314738.

PMID: 39921540 PMC: 11898231. DOI: 10.1177/17448069251314738.


The Intrinsic Neuronal Activation of the CXCR4 Signaling Axis Is Associated with a Pro-Regenerative State in Cervical Primary Sensory Neurons Conditioned by a Sciatic Nerve Lesion.

Dubovy P, Hradilova-Svizenska I, Brazda V, Jambrichova A, Svobodova V, Joukal M Int J Mol Sci. 2025; 26(1.

PMID: 39796050 PMC: 11720091. DOI: 10.3390/ijms26010193.


Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy.

Stoian A, Muntean C, Baba D, Manea A, Denes L, Simon-Szabo Z Int J Mol Sci. 2024; 25(19).

PMID: 39408723 PMC: 11476795. DOI: 10.3390/ijms251910395.


Exploring the role of spinal astrocytes in the onset of hyperalgesic priming signals in acid-induced chronic muscle pain.

Abdelaziz M, Chen W, Chang Y, Mindaye S, Chen C PNAS Nexus. 2024; 3(9):pgae362.

PMID: 39228816 PMC: 11370897. DOI: 10.1093/pnasnexus/pgae362.


Causal association between circulating inflammatory markers and sciatica development: a Mendelian randomization study.

Wu Y, Lin Y, Zhang M, He K, Tian G Front Neurol. 2024; 15:1380719.

PMID: 39015317 PMC: 11250389. DOI: 10.3389/fneur.2024.1380719.


References
1.
Boukhris S, Magy L, Khalil M, Sindou P, Vallat J . Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J Neurol Sci. 2007; 254(1-2):33-8. DOI: 10.1016/j.jns.2006.12.012. View

2.
Milligan E, Zapata V, Chacur M, Schoeniger D, Biedenkapp J, OConnor K . Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci. 2004; 20(9):2294-302. DOI: 10.1111/j.1460-9568.2004.03709.x. View

3.
Oh S, Tran P, Gillard S, Hurley R, Hammond D, Miller R . Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci. 2001; 21(14):5027-35. PMC: 6762869. View

4.
Xie W, Deng H, Li H, Bowen T, Strong J, Zhang J . Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia. Neuroscience. 2006; 142(3):809-22. PMC: 1661830. DOI: 10.1016/j.neuroscience.2006.06.045. View

5.
Tanaka T, Minami M, Nakagawa T, Satoh M . Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res. 2004; 48(4):463-9. DOI: 10.1016/j.neures.2004.01.004. View